» Articles » PMID: 19385708

Sex Differences in Pharmacokinetics and Pharmacodynamics

Overview
Specialty Pharmacology
Date 2009 Apr 24
PMID 19385708
Citations 381
Authors
Affiliations
Soon will be listed here.
Abstract

Significant differences that exist between the sexes affect the prevalence, incidence and severity of a broad range of diseases and conditions. Men and women also differ in their response to drug treatment. It is therefore essential to understand these reactions in order to appropriately conduct risk assessment and to design safe and effective treatments. Even from that modest perspective, how and when we use drugs can result in unwanted and unexpected outcomes. This review summarizes the sex-based differences that impact on pharmacokinetics, and includes a general comparison of clinical pharmacology as it applies to men, women and pregnant women. Sex-related or pregnancy-induced changes in drug absorption, distribution, metabolism and elimination, when significant, may guide changes in dosage regimen or therapeutic monitoring to increase its effectiveness or reduce potential toxicity. Given those parameters, and our knowledge of sex differences, we can derive essentially all factors necessary for therapeutic optimization. Since this is a rapidly evolving area, it is essential for the practitioner to review drug prescribing information and recent literature in order to fully understand the impact of these differences on clinical therapeutics.

Citing Articles

Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis.

Gross J, Jones M, Buige A, Prevots D, Kasperbauer S Ther Adv Respir Dis. 2025; 19:17534666251323181.

PMID: 40071337 PMC: 11898043. DOI: 10.1177/17534666251323181.


Polypharmacy Prevalence Among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe: An Update.

Bonanno E, Figueiredo T, Mimoso I, Morgado M, Carrilho J, Midao L J Clin Med. 2025; 14(4).

PMID: 40004860 PMC: 11856818. DOI: 10.3390/jcm14041330.


Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for and .

Annisa N, Afifah N, Santoso P, Yunivita V, Te Brake L, Aarnoutse R Antibiotics (Basel). 2025; 14(2).

PMID: 40001447 PMC: 11852071. DOI: 10.3390/antibiotics14020204.


Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure.

Singh S, Abu Y, Antoine D, Gomez D, Tao J, Truitt B Gut Microbes. 2025; 17(1):2464942.

PMID: 39950489 PMC: 11834462. DOI: 10.1080/19490976.2025.2464942.


Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity.

Osorio-Mendez J, Gomez-Grosso L, Montoya-Ortiz G, Novoa-Herran S, Dominguez-Romero Y Int J Mol Sci. 2025; 26(3).

PMID: 39940718 PMC: 11816698. DOI: 10.3390/ijms26030945.


References
1.
Anderson G . Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase. J Gend Specif Med. 2002; 5(1):25-33. View

2.
Calabrese V . A micromethod for absorption of specific antibody using an enzyme-linked immunosorbent assay (ELISA). J Neurosci Methods. 1984; 11(2):137-41. DOI: 10.1016/0165-0270(84)90031-1. View

3.
Umeh O, Currier J . Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opin Drug Metab Toxicol. 2006; 2(2):273-83. DOI: 10.1517/17425255.2.2.273. View

4.
Tamai I, Saheki A, Saitoh R, Sai Y, Yamada I, Tsuji A . Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters. J Pharmacol Exp Ther. 1997; 283(1):108-15. View

5.
Frezza M, Di Padova C, Pozzato G, Terpin M, BARAONA E, Lieber C . High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990; 322(2):95-9. DOI: 10.1056/NEJM199001113220205. View